Tempest Therapeutics

Tempest Therapeutics company information, Employees & Contact Information

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.

Company Details

Employees
22
Address
2000 Sierra Point Pkwy,
Phone
(415) 798-8589
Email
pa****@****ttx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Oncology.
HQ
Brisbane, California
Looking for a particular Tempest Therapeutics employee's phone or email?

Tempest Therapeutics Questions

News

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference - FinancialContent

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference FinancialContent

FDA Grants Fast Track Designation to Amezalpat for Hepatocellular Carcinoma - OncLive

FDA Grants Fast Track Designation to Amezalpat for Hepatocellular Carcinoma OncLive

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial - Yahoo Finance

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial Yahoo Finance

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Millendo Therapeutics in Ann Arbor to Merge with Tempest Therapeutics in $30M Deal - DBusiness Magazine

Millendo Therapeutics in Ann Arbor to Merge with Tempest Therapeutics in $30M Deal DBusiness Magazine

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance - Yahoo Finance

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance Yahoo Finance

Tempest Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Tempest Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

Sam Whiting, M.D., Ph.D., Joins Tempest as Executive Vice President and Chief Medical Officer - GlobeNewswire

Sam Whiting, M.D., Ph.D., Joins Tempest as Executive Vice President and Chief Medical Officer GlobeNewswire

Tempest Closes Merger with Millendo and Completes PIPE Financing - GlobeNewswire

Tempest Closes Merger with Millendo and Completes PIPE Financing GlobeNewswire

Top Tempest Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant